Dr Clive Glover, director, Strategy, Pall Corporation discusses recent industry developments surrounding cell and gene therapies and why safety is a key priority for this treatment area.
Ian and Reece are back, though they might be tripping over and getting their words muddled up, they talk about Covid-19 vaccine approvals, the EU's pandemic predicament and why Trump is back in the news.
Ian and Reece are back to discuss more news related to the pandemic, as well as another potential re-organisation in the NHS, investment in the UK life sciences sector and another report surrounding the digitisation of healthcare.
EPM speaks to Marcus Michel, CEO of ACG Group’s Engineering Division in Mumbai, India about the biggest industry challenges, his love of technology and the effect Covid-19 has had on business.
Adam Tetz director of Worldwide Marketing for Peli BioThermal looks at how tracking technologies can support supply chain monitoring and help ensure the protection of pharma payloads.
Hannah Bailey, business development director of Intoware, explains how digitalisation is helping pharma manufacturers meet digital workflow challenges.
Dr Tracy Brown, head of Life Sciences and Healthcare at TÜV SÜD National Engineering Laboratory explores the advances being made to reduce medical error with improved infusion drug delivery.
EPM speaks to Spirax Sarco to understand the role steam systems play in pharma and how the company can help improve sustainability throughout the industry.
EPM speaks to Lonza to learn about how to ensure good bioavailability across compounds and which therapy areas are benefitting from targeted drug delivery.
George I’ons - head of Product Strategy and Insights at Owen Mumford Pharmaceutical Services takes a deep dive into the state of the connected drug delivery device industry.
Sahana Mollah, senior manager, Global BioPharma Collaboration & CE Tech Marketing at SCIEX looks at how antibody variants are helping researchers develop new medicines.
